Annual report pursuant to Section 13 and 15(d)

Acquisition of Emerald Health Therapeutics, Inc - Assumptions to Value Warrants (Details)

v3.23.1
Acquisition of Emerald Health Therapeutics, Inc - Assumptions to Value Warrants (Details)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Nov. 10, 2022
Minimum      
Asset Acquisition [Line Items]      
Expected term (years) 5 years 5 years 3 months 7 days  
Maximum      
Asset Acquisition [Line Items]      
Expected term (years) 6 years 29 days 6 years 1 month 17 days  
Emerald Health Therapeutics Inc | EHT Warrants | Dividend yield      
Asset Acquisition [Line Items]      
Warrants and rights outstanding measurement input     0.0000
Emerald Health Therapeutics Inc | EHT Warrants | Volatility | Minimum      
Asset Acquisition [Line Items]      
Warrants and rights outstanding measurement input     1.029
Emerald Health Therapeutics Inc | EHT Warrants | Volatility | Maximum      
Asset Acquisition [Line Items]      
Warrants and rights outstanding measurement input     1.146
Emerald Health Therapeutics Inc | EHT Warrants | Risk-free interest rate | Minimum      
Asset Acquisition [Line Items]      
Warrants and rights outstanding measurement input     0.0429
Emerald Health Therapeutics Inc | EHT Warrants | Risk-free interest rate | Maximum      
Asset Acquisition [Line Items]      
Warrants and rights outstanding measurement input     0.0453
Emerald Health Therapeutics Inc | EHT Warrants | Expected term (years) | Minimum      
Asset Acquisition [Line Items]      
Expected term (years)     6 months 21 days
Emerald Health Therapeutics Inc | EHT Warrants | Expected term (years) | Maximum      
Asset Acquisition [Line Items]      
Expected term (years)     2 years 3 months 7 days